By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



35 Ehad Ha-Am Street

  Tel-Aviv  65202   Israel
Phone: n/a Fax: n/a


Company News
Alcobra (ADHD) Announces Election Of Dr. Joao Siffert To Board Of Directors 7/13/2015 7:16:12 AM
Alcobra (ADHD) To Present Results Of Phase II Fragile X Trial In A Conference Call & Webcast Presentation On Wednesday, June 24 6/24/2015 11:49:29 AM
Alcobra (ADHD)’s Fragile X Syndrome Drug Fails During Mid-Stage Trial 6/24/2015 7:23:42 AM
Alcobra (ADHD) To Present At Two Conferences In June 5/28/2015 7:09:15 AM
Alcobra (ADHD) Announces First Quarter 2015 Financial Results And Provides Corporate Update 5/6/2015 11:00:40 AM
Alcobra (ADHD) To Participate At Two Conferences In May 4/27/2015 10:20:24 AM
Alcobra (ADHD) To Release First Quarter 2015 Financial Results And Host Corporate Update Conference Call & Webcast On May 6 4/16/2015 7:54:22 AM
Alcobra (ADHD) To Present At Two CNS Focused Conferences In April 4/6/2015 7:26:29 AM
Alcobra (ADHD)'s MDX Meets Primary Endpoint In Phase II Safety And Tolerability Clinical Trial In Adolescents With ADHD 3/10/2015 7:27:54 AM
Alcobra (ADHD) To Present At 27th Annual ROTH Conference 3/3/2015 8:46:13 AM